Correlation Between Teva Pharmaceutical and ICL Israel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharmaceutical and ICL Israel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharmaceutical and ICL Israel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharmaceutical Industries and ICL Israel Chemicals, you can compare the effects of market volatilities on Teva Pharmaceutical and ICL Israel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharmaceutical with a short position of ICL Israel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharmaceutical and ICL Israel.

Diversification Opportunities for Teva Pharmaceutical and ICL Israel

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Teva and ICL is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and ICL Israel Chemicals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICL Israel Chemicals and Teva Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharmaceutical Industries are associated (or correlated) with ICL Israel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICL Israel Chemicals has no effect on the direction of Teva Pharmaceutical i.e., Teva Pharmaceutical and ICL Israel go up and down completely randomly.

Pair Corralation between Teva Pharmaceutical and ICL Israel

Assuming the 90 days trading horizon Teva Pharmaceutical is expected to generate 5.36 times less return on investment than ICL Israel. In addition to that, Teva Pharmaceutical is 1.35 times more volatile than ICL Israel Chemicals. It trades about 0.02 of its total potential returns per unit of risk. ICL Israel Chemicals is currently generating about 0.18 per unit of volatility. If you would invest  145,431  in ICL Israel Chemicals on November 3, 2024 and sell it today you would earn a total of  67,569  from holding ICL Israel Chemicals or generate 46.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Teva Pharmaceutical Industries  vs.  ICL Israel Chemicals

 Performance 
       Timeline  
Teva Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Teva Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
ICL Israel Chemicals 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in ICL Israel Chemicals are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, ICL Israel sustained solid returns over the last few months and may actually be approaching a breakup point.

Teva Pharmaceutical and ICL Israel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharmaceutical and ICL Israel

The main advantage of trading using opposite Teva Pharmaceutical and ICL Israel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharmaceutical position performs unexpectedly, ICL Israel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICL Israel will offset losses from the drop in ICL Israel's long position.
The idea behind Teva Pharmaceutical Industries and ICL Israel Chemicals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements